METTL16 and neoplasm: Collectively, these data demonstrate that METTL16 overexpression promoted HCC cellular migration, invasion, and proliferation, inhibited HCC cellular apoptosis, and promoted HCC tumor growth in vivo, indicating that METTL16 overexpression has oncogenic roles in HCC.